40
Participants
Start Date
December 31, 2002
Primary Completion Date
July 31, 2009
Study Completion Date
August 31, 2010
capecitabine, imatinib mesylate
Capecitabine and imatinib mesylate will both be taken by mouth twice a day
USC/Norris Cancer Center, Los Angeles
Collaborators (1)
Novartis
INDUSTRY
University of Southern California
OTHER